Single Cell Analysis Companies

The single-cell analysis market is expected to grow significantly, reaching USD 7.56 billion by 2030 from an estimated USD 3.81 billion in 2025, at a CAGR of 14.7% during the forecast period. Several factors are driving growth in the single-cell analysis market, including advancements in technology related to single-cell analysis products, increased research & development in the pharmaceutical and biotechnology sectors, and growth in stem cell research. Additionally, a rising emphasis on personalized medicine and the increasing prevalence of cancer are further boosting market growth. Furthermore, integrating microfluidics with single-cell analysis and the high growth potential of single-cell sequencing are expected to create additional opportunities for market expansion in the coming years. However, the high costs associated with single-cell analysis products could challenge market growth.

The global single-cell analysis market is highly competitive, featuring leading companies like BD (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), 10X Genomics (US), and Merck KGaA (Germany). These market players have implemented various strategies, including new product launches, acquisitions, agreements, collaborations, and geographic expansions, to enhance their positions in the market.

To know about the assumptions considered for the study download the pdf brochure

BD (US)

BD (Becton, Dickinson, and Company) develops, manufactures, and distributes medical instruments and reagents. The company's products are used in various applications, including biosciences, diabetes care, respiratory disorder management, and diagnostic and analytical applications. BD operates in over 50 countries across Europe, Latin America, the Asia Pacific, and North America. The company is also committed to developing innovative products. For example, in February 2023, BD launched a new instrument for single-cell multiomics analysis, which allows scientists to conduct high-throughput studies without compromising sample integrity. This advancement has the potential to accelerate discovery across a wide range of fields, including immunology, genetic disease research, cancer, and chronic disease research.

Thermo Fisher Scientific Inc. (US)

Thermo Fisher is a leading company in science and technology, specializing in manufacturing high-end analytical instruments, laboratory equipment, software, consumables, reagents, and services for scientific research, analysis, discovery, and diagnostics. The company operates in over 180 countries across North America, Europe, Asia, the Middle East, Africa, and Latin America. Thermo Fisher forms strategic alliances to strengthen its global presence, including collaborations and partnerships.

In November 2021, Thermo Fisher Scientific Inc. partnered with CELLENION to develop workflows for single-cell, mass spectrometry-based proteomics analyses. This partnership aims to combine CELLENION's CellenOne single-cell isolation system and ProteoChip consumables with Thermo Fisher's TMT multiplexing technologies and Orbitrap mass spectrometers. Together, they will create workflows for single-cell isolation and automate sample preparation for mass spectrometry-based proteomics analysis at the single-cell level.

Danaher Corporation (US)

Danaher Corporation is a leading innovator in life sciences and diagnostics, offering a wide range of products and services for medical, industrial, and commercial applications. The company has a strong presence in North America, Europe, Asia, and Latin America. Moreover, Danaher Corporation focuses on strategic alliances to enhance its global reach. In October 2023, Danaher Corporation partnered with 10X Genomics to expand automation solutions for single-cell assay workflows through its Beckman Colter Life Sciences division.

Market Ranking

The single-cell analysis market is highly consolidated, dominated by five main players who collectively hold approximately 75–80% of the total market share. BD (US) leads the market with a 22.8% share, reflecting its extensive influence through a diverse product portfolio. Thermo Fisher Scientific Inc. (US) follows BD with a 20.9% market share. Other significant players include Danaher Corporation (US) with 16.2%, 10X Genomics (US) with 12.2%, and Merck KGaA (Germany) with 6.4%.

Regional and emerging players hold the remaining 20–25% of the market, leading to significant consolidation. Competition in this market is driven by several key factors, including technological advancements, product innovation, strategic partnerships, and growing demand from pharmaceutical and biopharmaceutical companies.

Related Reports:

Single Cell Analysis Market by Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2030)

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com